Controlled field trials of killed oral typhoid and paratyphoid B vaccines and cell-free, chemical aerosol typhoid vaccine. 1976

L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva

Three controlled field trials were carried out. One of them (1963) showed that an aerosol with cell-free, chemical typhoid vaccine did not protect vaccinees from the disease. The other trials (1964 and 1965) assessing the efficacy of killed oral typhoid vaccine revealed a short term (up to 3 months) protective effect. In the trial of oral paratyphoid B vaccine no statistically significant difference in morbidity in the test and control groups was observed due to the small number of cases.

UI MeSH Term Description Entries
D010284 Paratyphoid Fever A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe. Fever, Paratyphoid,Fevers, Paratyphoid,Paratyphoid Fevers
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D014435 Typhoid Fever An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA. Enteric Fever,Typhus, Abdominal,Salmonella typhi Infection,Typhoid,Abdominal Typhus,Enteric Fevers,Fever, Enteric,Fever, Typhoid,Fevers, Enteric,Fevers, Typhoid,Infection, Salmonella typhi,Infections, Salmonella typhi,Salmonella typhi Infections,Typhoid Fevers,Typhoids

Related Publications

L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1976, Journal of hygiene, epidemiology, microbiology, and immunology,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1976, Journal of hygiene, epidemiology, microbiology, and immunology,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1972, International journal of epidemiology,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1976, Developments in biological standardization,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1976, Developments in biological standardization,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1970, Progress in immunobiological standardization,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1977, Bulletin of the World Health Organization,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
November 1951, Medizinische Monatsschrift,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
January 1971, Bulletin of the World Health Organization,
L B Hejfec, and L A Levina, and L B Salmin, and A A Antonova, and L S Segal, and M L Kuzminova, and K M Slavina, and A V Vasileva
June 1973, Bulletin of the World Health Organization,
Copied contents to your clipboard!